AnaptysBio (ANAB) PT Lowered to $93 at Piper Sandler
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $67.31 +8.02%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 48
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 48
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi lowered the price target on AnaptysBio (NASDAQ: ANAB) to $93.00 (from $95.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Intercontinental Exchange (ICE) PT Lowered to $190 at UBS Following June Metrics Release
- Telix Pharmaceuticals Ltd (TLX) PT Lowered to $22 at Citi
- Hain Celestial (HAIN) PT Lowered to $0.81 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
